CARE International

Views & Analysis

Live Well brings health products to the doorsteps of rural Zambians in an innovative partnership between GSK and CARE International.

News

Hengrui's oral TPO agonist, hetrombopag, is the first in the class to be approved for thrombocytopenia caused by chemotherapy for solid tumours.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.